Leah has held multiple positions in industry including roles at Ingene, Bristol Myers Squibb, Boehringer Ingelheim, Purdue Pharma, UCB, Elan Drug Technologies and Regeneron. Initially, her focus was in research of biologicals, particularly therapeutic monoclonal antibodies in the treatment of cancer and infectious disease. Leah has focused her career on product development and seeing important discoveries make it through the development pathway. Throughout her career, Leah has been presented with numerous opportunities to move drug candidates through to IND/CTA, and ultimately, NDA/BLA. Leah has equivalent experience in both NCE and NBE development in varied dosage forms and has taken many products into development and ultimately to the marketplace.